000 | 01587 a2200445 4500 | ||
---|---|---|---|
005 | 20250514233016.0 | ||
264 | 0 | _c20050919 | |
008 | 200509s 0 0 eng d | ||
022 | _a1526-8209 | ||
024 | 7 |
_a10.3816/cbc.2005.n.015 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHudis, Clifford A | |
245 | 0 | 0 |
_aWeekly epoetin alfa during adjuvant chemotherapy for breast cancer: effect on hemoglobin levels and quality of life. _h[electronic resource] |
260 |
_bClinical breast cancer _cJun 2005 |
||
300 |
_a132-42 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase IV; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAnemia _xchemically induced |
650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
650 | 0 | 4 | _aChemotherapy, Adjuvant |
650 | 0 | 4 | _aEpoetin Alfa |
650 | 0 | 4 |
_aErythropoietin _xadministration & dosage |
650 | 0 | 4 | _aFatigue |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHematinics _xadministration & dosage |
650 | 0 | 4 |
_aHemoglobins _xanalysis |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInjections, Subcutaneous |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 | _aQuality of Life |
650 | 0 | 4 | _aRecombinant Proteins |
650 | 0 | 4 | _aSeverity of Illness Index |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aVogel, Charles L | |
700 | 1 | _aGralow, Julie R | |
700 | 1 | _aWilliams, Denise | |
773 | 0 |
_tClinical breast cancer _gvol. 6 _gno. 2 _gp. 132-42 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3816/cbc.2005.n.015 _zAvailable from publisher's website |
999 |
_c15658479 _d15658479 |